Drugs / Haporine-S
last change Feb 2014 re-read 2 minutes ago

Haporine-S

Developed for
dry eye syndrome
Investigated by
BTO Pharm. Co., Ltd. · DH Bio Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01804361 Mar 2013 → Feb 2014 dry eye syndrome DH Bio Co., Ltd. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Haporine-S ClinicalTrials.gov intervention name — accepted as the source's own label NCT01804361
Route Topical “Haporine-S eye drop” NCT01804361